コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 eloped to identify AMR bacteria in the River Thames.
2 r reversed the effects of HC on AC activity (THAM 103%, HCO(3) 113% of NC cAMP, ns; Forskolin 168%, p
3 ns; Forskolin 168%, p < 0.05) and PM repair (THAM 87%, HCO(3) 108% of NC likelihood to repair, ns; Fo
5 onal six pigs (sham group) were infused with THAM, and an equal volume of fluid as the 12 coagulopath
6 es are needed to confirm these observations, THAM appears to be an effective alternative to sodium bi
7 t changes to mussel populations in the River Thames are likely to have occurred over the half century
9 , the actual incidence rates observed by the Thames Cancer Registry during the same calendar period o
17 f Homo erectus and Gigantopithecus blacki at Tham Khuyen helps to establish the long co-existence of
23 40 Torr) or HC (80 Torr), +/- tromethamine (THAM) or sodium bicarbonate (HCO3) +/- AC probes in a mi
25 he effect of tris-hydroxymethylaminomethane (THAM) pH neutralization on reversing coagulation abnorma
29 benthic sediment from 34 stations along the Thames River in Ontario, Canada, to determine the influe
32 itor ECs at the catchment scale in the River Thames system (U.K.) and explored their sources and envi
34 In an uncontrolled study, we administered THAM to 10 patients with acidosis (mean pH = 7.14) and A
35 ved, the pigs were infused with either 0.3 M THAM to achieve pH of 7.4 (intervention group) or an equ
37 n freshwater mussel populations in the River Thames, UK, continues to be cited extensively as evidenc
38 rapa and cultivated B. napus along the river Thames, UK, in 1997 and 1998, suggests mixed stands will
41 HR), NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research
42 ion, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research
43 ons, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research
44 ion, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research
45 ons, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midlands NIHR Clinical Research
46 ciences Innovation Fund for Medical Science, Thames Valley and South Midlands NIHR Clinical Research
47 ons, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midlands NIHR Clinical Research
48 tional Institute for Health Research (NIHR), Thames Valley Primary Care Research Partnership, and the
50 ren aged 13-48 months (nasopharyngeal swabs, Thames Valley, UK) and national IPD data, 2014-2019.
51 dication to exercise were recruited from the Thames valley, UK, and randomised (1:1) to intervention